Cleared Traditional

K121825 - CS-MAG II

K121825 is an FDA 510(k) clearance for CS-MAG II, manufactured by Biomagnetik-Park GmbH. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 263-day FDA review.

K121825 · Biomagnetik-Park GmbH · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2013
Decision
263d
Days
Class 2
Risk

K121825 is an FDA 510(k) clearance for the CS-MAG II. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Biomagnetik-Park GmbH (Hamburg, DE). The FDA issued a Cleared decision on March 11, 2013 after a review of 263 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biomagnetik-Park GmbH devices

FDA 510(k) Submission Details - K121825

510(k) Number K121825 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 2012
Decision Date March 11, 2013
Days to Decision 263 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
138d slower than avg
Panel avg: 125d · This submission: 263d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 317
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K121825.
PHILIPS DXL 12/16-LEAD ECG ALGORITHM
K132068 · Philips Medical Systems · Sep 2013
ALIVECOR HEART MONITOR
K130409 · AliveCor, Inc. · Sep 2013
CP150 ELECTROCARDIOGRAPH
K131573 · Welch Allyn, Inc. · Jul 2013
QT GUARD PLUS ANALYSIS SYSTEM
K120770 · Ge Medical Systems Information Technologies · Dec 2012
ALIVECOR HEART MONITOR FOR IPHONE
K122356 · AliveCor, Inc. · Nov 2012
ELI 280 ELECTROCARDIOGRAPH
K122073 · Mortara Instrument, Inc. · Aug 2012